Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
17.18
+0.14 (0.82%)
Nov 20, 2024, 4:00 PM EST - Market closed
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of 24.5, with a low estimate of 24 and a high estimate of 25. The average target predicts an increase of 42.61% from the current stock price of 17.18.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ANIK stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +45.52% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +115.37% | Oct 22, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +115.37% | Aug 9, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $24 | Hold | Reiterates | $24 | +39.70% | May 29, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +115.37% | May 9, 2024 |
Financial Forecast
Revenue This Year
153.20M
from 166.66M
Decreased by -8.08%
Revenue Next Year
116.79M
from 153.20M
Decreased by -23.77%
EPS This Year
-2.68
from -5.64
EPS Next Year
-0.20
from -2.68
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 158.8M | 121.8M | 131.3M | ||
| Avg | 153.2M | 116.8M | 126.7M | ||
| Low | 146.2M | 110.7M | 121.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.7% | -20.5% | 12.4% | ||
| Avg | -8.1% | -23.8% | 8.5% | ||
| Low | -12.3% | -27.7% | 3.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.54 | -0.13 | 0.89 | ||
| Avg | -2.68 | -0.20 | 0.36 | ||
| Low | -2.78 | -0.27 | -0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.